officialstreetpreachers Subscribe
Published: January 19, 2022

Pfizer continuing to profit from COVID as it announces new omicron-specific booster jab

By The Editor
lifesite

Wed Jan 19, 2022 – 8:57 am EST STORY AT-A-GLANCE Omicron is rapidly overtaking other SARS-CoV-2 variants and currently accounts for 95% of all COVID cases in the U.S. Research shows current COVID shots cease to provide any protection against Omicron 30 days’ post-injection, and at 90 days offers negative protection, actually making you more prone to Omicron infection This effectively makes COVID jab mandates obsolete, yet government and health authorities are still pushing Americans to get jabbed, and if already jabbed, to get a third booster Pfizer is now saying it will have an Omicron-specific shot ready in March 2022, at which point Americans will undoubtedly be told to line up for a fourth injection Professor Andrew Pollard, head of the U.K.’s Committee on Vaccination and Immunization who helped create the Oxford-AstraZeneca shot, said in a January 3, 2022, Daily Telegraph interview: “We can’t vaccinate the planet every four or six months. It’s not sustainable or affordable”

(Mercola) – While a third COVID booster shot started rolling out in late September 2021, and people have been bullied into getting it, that booster is no different from the first two doses. It’s not specific against

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors


Share this Article

Download the Mobile App.
Exit mobile version